FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to medicine and deals with agent for prevention and treatment of diabetic peripheral neuropathy, which includes as an active agent granulocytic colony-stimulating factor (G-CSF).
EFFECT: invention ensures increase of nerve conduction rate, improvement of pain sensitivity, regeneration of blood vessels in peripheral tissues and rehabilitation of affected nerve tissues.
6 cl, 2 ex, 7 dwg, 7 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| USE OF CARBAMATE COMPOUND FOR PREVENTION, RELIEF, OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY OR PERIPHERAL NEUROPATHY INDUCED BY CHEMOTHERAPY | 2019 |
|
RU2783733C1 |
| NEUROTROPIC TACROLIMUS ANALOGS | 2001 |
|
RU2288716C2 |
| COMBINATION , CONTAINING HERB COMBINATION EXTRACT, FOR PREVENTION OR TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY | 2011 |
|
RU2566721C2 |
| METHOD FOR GENE THERAPY TREATMENT OF DIABETIC FOOT SYNDROME | 2015 |
|
RU2599507C1 |
| FUSED PROTEIN OR PEPTIDE WITH INCREASED HALF LIFETIME IN VIVO, WHICH IS MAINTAINED DUE TO SLOW RELEASE IN VIVO, AND METHOD FOR INCREASING HALF LIFETIME IN VIVO USING IT | 2010 |
|
RU2503688C2 |
| COMBINATIONS OF PALMITOYLETHANOLAMIDE FOR TREATING CHRONIC PAIN | 2018 |
|
RU2701720C1 |
| METHOD FOR ASSESSING THE CLINICAL EFFECTIVENESS OF TYPE 2 DIABETES MELLITUS | 2018 |
|
RU2701174C1 |
| METHOD OF TREATING MULTIPLE SCLEROSIS | 2010 |
|
RU2539034C2 |
| N-[2-HYDROXY-3(1-PIPERIDINYL)-PROPOXY]-PYRIDINE-1-OXYDE-3- CARBOXYIMIDOYL CHLORIDE, PHARMACEUTICAL COMPOSITION CONTAINING THE SAME AND TREATMENT METHOD | 2000 |
|
RU2250901C2 |
| METHOD OF TREATMENT OF DIABETIC PERIPHERAL POLYNEUROPATHY | 2006 |
|
RU2323751C1 |
